Artiva Biotherapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Artiva Biotherapeutics, Inc. (ARTV) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents40.2453.50102.53160.9225.44
Short-Term Investments145.1923.470.000.000.00
Cash & Short-Term Investments185.4376.97102.53160.9225.44
Accounts Receivable0.151.860.530.470.00
Inventory0.000.000.000.000.00
Other Current Assets3.060.991.620.900.67
Total Current Assets188.6379.82104.68162.2926.11
Non-Current Assets
Property, Plant & Equipment (Net)20.4324.6427.614.082.39
Other Non-Current Assets0.530.650.760.390.14
Total Non-Current Assets20.9525.2928.377.640.00
Total Assets209.58105.11133.05169.9329.23
Current Liabilities
Accounts Payable1.120.611.101.442.15
Short-Term Debt7.480.000.000.000.00
Accrued Liabilities7.398.0210.1510.133.16
Deferred Revenue0.000.0010.897.300.00
Other Current Liabilities3.650.000.000.000.00
Total Current Liabilities12.2512.2325.6319.315.76
Non-Current Liabilities
Long-Term Debt10.6113.3215.961.310.00
Other Non-Current Liabilities0.0725.170.120.085.31
Total Non-Current Liabilities10.69254.90248.13239.480.00
Total Liabilities22.9450.72273.75258.7812.73
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-246.68-181.31-152.59-93.80-21.98
Accumulated Other Comprehensive Income-0.130.310.000.000.00
Additional Paid-in Capital433.4518.9911.904.950.00
Shares Outstanding24.2923.2823.2823.280.00
Total Stockholders' Equity186.6454.40-140.70-88.8616.50
Total Liabilities & Equity209.58105.11133.05169.930.00